IXHLNasdaqPharmaceutical PreparationsFiscal year ends June 30
Incannex Healthcare Inc.
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Sep 25, 2026
$2.76−0.06 (-2.13%)
Close on Oct 19, 2026
- Market cap
- $33.89M
- P/E (TTM)
- –
- Dividend yield
- –
Incannex Healthcare statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Incannex Healthcare | Industry median |
|---|---|---|
| Market Cap | $34.62M | $166.30M |
| Enterprise Value | -$33.09M | $87.12M |
| PB Ratio | 0.51 | 2.03 |
| P/TBV Ratio | 0.51 | 2.31 |
Income (trailing twelve months)
| Measure | Incannex Healthcare | Industry median |
|---|---|---|
| Operating Income | -$23.03M | -$21.49M |
| Pretax Income | -$19.30M | -$14.72M |
| Net Income | -$19.30M | -$22.46M |
| EBITDA | -$22.79M | -$17.14M |
| EPS (Diluted) | -$1.66 | -$0.83 |
Returns
| Measure | Incannex Healthcare | Industry median |
|---|---|---|
| Return on Equity (ROE) | -47.8% | -53.2% |
| Return on Assets (ROA) | -41.3% | -41.0% |
| Return on Capital Employed (ROCE) | -32.2% | -38.0% |
Balance sheet
| Measure | Incannex Healthcare | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $67.71M | $62.64M |
| Net Cash (Debt) | $67.71M | $15.77M |
| Net Cash Per Share | $5.40 | $0.66 |
| Equity (Book Value) | $67.37M | $48.61M |
| Book Value Per Share | $5.37 | $1.36 |
| Tangible Book Value | $67.37M | $23.01M |
| Working Capital | $71.34M | $75.09M |
Financial position
| Measure | Incannex Healthcare | Industry median |
|---|---|---|
| Current Ratio | 48.81 | 3.30 |
| Quick Ratio | 45.38 | 2.39 |
Cash flow (trailing twelve months)
| Measure | Incannex Healthcare | Industry median |
|---|---|---|
| Operating Cash Flow | -$12.87M | -$12.39M |
| Capital Expenditures | -$10.00K | -$1.07M |
| Free Cash Flow | -$12.88M | -$20.34M |
| FCF Per Share | -$1.03 | -$0.42 |
Efficiency
| Measure | Incannex Healthcare | Industry median |
|---|---|---|
| Profits Per Employee | -$1.61M | -$705.27K |
| Employee Count | 12 | 74 |
Dividends and yields
| Measure | Incannex Healthcare | Industry median |
|---|---|---|
| Earnings Yield | -55.7% | -22.8% |
| FCF Yield | -37.2% | -9.02% |
| Buyback Yield | -200.1% | -0.73% |
| Shareholder Yield | -200.1% | 0.00% |
Shares
| Measure | Incannex Healthcare | Industry median |
|---|---|---|
| Shares Outstanding | 12,544,600 | 58,139,000 |
| Shares Change (QoQ) | -8.32% | 0.54% |
| Shares Held by Institutions | 3.62% | 59.4% |
Scores
| Measure | Incannex Healthcare | Industry median |
|---|---|---|
| Altman Z-Score | 0.44 | -0.27 |
| Piotroski F-Score | 4 | 4 |
Calculated by StockData from Incannex Healthcare's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.